Heron Therapeutics Inc (HRTX)

SG&A Expense Growth

-3.84%

Quarterly · Period ending:

HRTX logo

HRTX SG&A Expense Growth

Latest reported-3.84%
HRTX Quarterly SG&A Growth (QoQ) (0.00% → -3.84%)
High-resolution chart · PNG

HRTX sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Heron Therapeutics Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
6.3907%
-11.9634%
5.9244%
-3.1819%
-40.9266%
-53.8182%
106.25%
0%
0%
33.3333%
-20%
-6.25%
0%
-5.8824%
0%
-15%
0%
-16.6667%
-22.5806%
-3.125%
18.5185%
0%
12.5%
0%
14.2857%
-8.6957%
21.0526%
-13.6364%
0%
-54.1667%
14.2857%
-6.6667%
45.1613%
29.1667%
20%
-13.0435%
9.5238%
75%
0%
-14.2857%
16.6667%
-7.6923%
0%
-7.1429%
27.2727%
-21.4286%
7.6923%
-40.9091%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.